On Monday, Jefferies, a global investment banking firm, updated its outlook on shares of Northrop Grumman (NYSE:NOC), a major defense contractor, increasing the stock's price target to $550 from $520, while maintaining a Hold rating on the shares.
The adjustment follows Northrop Grumman's third-quarter financial results, which, despite a top-line miss attributed to timing, showcased better margin performance. The company has set a growth target between 3 to 4% leading up to 2025, with some headwinds expected from Space Systems. However, revenues are anticipated to pick up pace in 2026.
The firm highlighted Northrop Grumman's free cash flow (FCF) growth as a significant driver of its financial performance, pointing to operational improvements and capital expenditure rationalization. These factors are expected to contribute to over 30% growth in FCF per share by 2025.
Despite the positive aspects, the analyst noted potential limitations to the stock's upward movement, considering the dynamics on the supply side. Moreover, the forecasted free cash flow yield of 4.0% for the following year is slightly above the market average, suggesting that the current stock price may already reflect the company's strong performance.
In other recent news, Northrop Grumman reported robust financial performance in its third quarter of 2024, with earnings per share increasing by 13% from the same quarter of the previous year and a year-to-date revenue growth of 6%.
The company's backlog reached a record $85 billion, more than double its annual revenue, indicating strong future demand. Susquehanna and UBS analysts maintained positive ratings on Northrop Grumman's shares and raised their price targets following these results.
Susquehanna highlighted the company's strong trajectory towards meeting the full-year 2024 free cash flow estimate of $2.5 billion and the anticipated decrease in capital expenditures, which are expected to contribute to significant free cash flow growth.
Meanwhile, UBS pointed to Northrop Grumman's steady operational performance despite industry challenges and the potential for high-quality growth, margin expansion, and increased free cash flow.
Looking ahead, Northrop Grumman expects a sales increase of 3-4% in 2025, with a focus on international markets and new development programs. The B-21 program and the Sentinel contract remain high-priority programs and key growth drivers for the company. These recent developments underscore Northrop Grumman's strong position in the defense industry and its promising growth prospects.
InvestingPro Insights
Building on Jefferies' analysis, recent data from InvestingPro provides additional context to Northrop Grumman's financial position. The company's market capitalization stands at $75.67 billion, reflecting its significant presence in the Aerospace & Defense industry. Northrop Grumman's revenue for the last twelve months as of Q3 2024 reached $40.98 billion, with a growth rate of 5.95%, aligning with the company's target growth range mentioned in the article.
InvestingPro Tips highlight Northrop Grumman's strong dividend history, having raised its dividend for 20 consecutive years and maintained payments for 54 years. This consistent dividend growth, with a 10.16% increase in the last twelve months, underscores the company's financial stability and commitment to shareholder returns.
The stock's P/E ratio of 32.47 and high Price / Book multiple of 5.13 suggest that investors are pricing in future growth expectations, which corresponds with the analyst's view on potential limitations to stock price appreciation. However, the company's profitability and high return over the last decade, as noted in the InvestingPro Tips, provide a solid foundation for the positive outlook on free cash flow growth mentioned in the article.
For investors seeking a deeper understanding of Northrop Grumman's financial health and market position, InvestingPro offers 11 additional tips, providing a comprehensive analysis to inform investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.